Published in J Virol on February 01, 1981
Antiviral activities of hybrids of two major human leukocyte interferons. Nucleic Acids Res (1981) 1.56
Initial characterization of a spontaneous interferon secreted during growth and differentiation of Friend erythroleukemia cells. Mol Cell Biol (1982) 1.21
Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication. J Virol (1988) 1.10
Differential antiviral effects of interferon in three murine cell lines. J Virol (1983) 1.07
Signal transduction pathways in the induction of 2',5'-oligoadenylate synthetase gene expression by interferon alpha/beta. Proc Natl Acad Sci U S A (1989) 1.02
Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2'-5')oligoadenylate synthetase activity. Mol Cell Biol (1983) 0.97
Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon. J Virol (1981) 0.86
Effect of type-I interferon on retroviruses. Viruses (2009) 0.75
Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol (1963) 29.15
Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol (1969) 11.78
Rapid cell culture assay technic for murine leukaemia viruses. Nature (1971) 5.87
On the varied biologic effects of interferon. Cell Immunol (1977) 2.47
Antiviral activity of interferons. Bacteriol Rev (1977) 2.25
Selective degradation of integrated murine leukemia proviral DNA by deoxyribonucleases. Cell (1977) 2.22
Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth. Nature (1978) 1.52
Binding of tRNA to reverse transcriptase of RNA tumor viruses. J Virol (1978) 1.51
Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci U S A (1980) 1.20
Effects of interferon on cell and virus growth in transformed human cell lines. J Gen Virol (1976) 1.11
Differential effect of interferon on DNA synthesis, 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumor promotors. J Cell Physiol (1980) 1.06
Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. Int J Cancer (1977) 0.98
Rapid quantitation of interferon with chronically oncornavirus-producing cells. Infect Immun (1976) 0.96
Selective inhibition by interferon of serum-stimulated biochemical events in 3T3 cells. Biochem Biophys Res Commun (1979) 0.90
Physical characterization and simultaneous purification of bacteriophage T4 induced polynucleotide kinase, polynucleotide ligase, and deoxyribonucleic acid polymerase. Biochemistry (1973) 11.45
Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives. Proc Natl Acad Sci U S A (1971) 5.31
Ordered transcription of RNA tumor virus genomes. J Mol Biol (1976) 4.78
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 3.67
Replication of semliki forest virus: three forms of viral RNA produced during infection. Proc Natl Acad Sci U S A (1966) 3.23
Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol (1968) 3.04
Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis. J Virol (1977) 2.99
Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase (reverse transcriptase). Proc Natl Acad Sci U S A (1975) 2.97
Cytoplasmic fractions associated with Semliki Forest virus ribonucleic acid replication. J Virol (1967) 2.29
Quantitation of avian RNA tumor virus reverse transcriptase by radioimmunoassay. J Virol (1975) 2.27
Antiviral activity of interferons. Bacteriol Rev (1977) 2.25
Selective degradation of integrated murine leukemia proviral DNA by deoxyribonucleases. Cell (1977) 2.22
Analysis of arbovirus ribonucleic acid forms by polyacrylamide gel electrophoresis. J Virol (1971) 2.10
Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J Virol (1972) 2.00
In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol (1984) 1.98
Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis (1982) 1.98
Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 1. General introduction. J Biol Chem (1976) 1.91
Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo. Infect Immun (1988) 1.89
The anti-chlamydial and anti-proliferative activities of recombinant murine interferon-gamma are not dependent on tryptophan concentrations. J Immunol (1985) 1.83
Membrane-associated replication complex in arbovirus infection. J Virol (1972) 1.83
Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells. J Virol (1991) 1.81
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections. Infect Immun (1989) 1.74
The epidemiology of childhood psychiatric disorders: prevalence findings from recent studies. J Am Acad Child Adolesc Psychiatry (1990) 1.73
Recombinant human gamma interferon inhibits simian malaria. Infect Immun (1986) 1.71
Interferons with special emphasis on the immune system. Adv Immunol (1983) 1.69
Membrane binding of input arbovirus ribonucleic acid: effect of interferon or cycloheximide. J Virol (1970) 1.66
Replication of Western equine encephalomyelitis virus. I. Some chemical and physical characteristics of viral ribonucleic acid. J Virol (1968) 1.66
Inhibition of interferon action by puromycin. J Immunol (1965) 1.65
Protein synthesis directed by an arbovirus. J Virol (1968) 1.63
Heterogeneous RNA's occurring during the replication of Western equine encephalomyelitis virus. Proc Natl Acad Sci U S A (1966) 1.62
Recurrent digital ischemia due to thrombosis of the persistent median artery. Plast Reconstr Surg (1997) 1.61
Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J Virol (1984) 1.60
Simian virus 40-specific ribosome-binding proteins induced by a nondefective adenovirus 2-simian virus 40 hybrid. J Virol (1977) 1.59
Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem (2001) 1.59
Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J Virol (2000) 1.55
Lysyl oxidase and rrg messenger RNA. Science (1991) 1.55
Specific membranous structures associated with the replication of group A arboviruses. J Virol (1972) 1.54
A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med (1990) 1.53
Sindbis virus-induced viral ribonucleic acid polymerase. J Virol (1969) 1.53
Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science (1990) 1.53
Binding of tRNA to reverse transcriptase of RNA tumor viruses. J Virol (1978) 1.51
Replicative intermediate of an arbovirus. J Virol (1968) 1.51
Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon. Proc Natl Acad Sci U S A (1974) 1.50
Effect of interferon treatment on interferon production. J Immunol (1966) 1.49
Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers. J Virol (1975) 1.49
Internal stabilization of autogenous rib cartilage grafts in rhinoplasty: a barrier to cartilage warping. Plast Reconstr Surg (1997) 1.48
Potentiation of human interferon production by superinduction. J Natl Cancer Inst (1971) 1.47
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc Natl Acad Sci U S A (1982) 1.46
Interferon binding: the first step in establishment of antiviral activity. Science (1967) 1.45
Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction. J Immunol (1990) 1.44
Imaging transgene expression in live animals. Mol Ther (2001) 1.43
Growth inhibition and morphological changes caused by lipophilic acids in mammalian cells. Proc Natl Acad Sci U S A (1973) 1.41
Interferon-induced inhibition of Chlamydia trachomatis: dissociation from antiviral and antiproliferative effects. Infect Immun (1985) 1.41
Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J Gen Virol (1988) 1.41
Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J Virol (1998) 1.40
Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity. Br J Ophthalmol (2001) 1.39
Caring for severely emotionally disturbed children and youth. Principles for a system of care. Child Today (1988) 1.39
Interaction of tryptophan tRNA and avian myeloblastosis virus reverse transcriptase: further characterization of the binding reaction. Biochemistry (1977) 1.39
Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product. J Virol (1990) 1.37
Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J Cell Biochem (1993) 1.37
The binding of purified Phe-tRNA and peptidyl-tRNA Phe to Escherichia coli ribosomes. Eur J Biochem (1971) 1.35
Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS (1998) 1.33
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
Structural and nonstructural proteins of an arbovirus. J Virol (1968) 1.33
Ultrastructural analysis of the anti-chlamydial activity of recombinant murine interferon-gamma. Exp Mol Pathol (1987) 1.32
Interferon inhibits mouse leukaemia virus release: an electron microscope study. J Gen Virol (1977) 1.31
Role of the subunits of the avian RNA tumor virus reverse transcriptase. Cold Spring Harb Symp Quant Biol (1975) 1.30
Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett (2001) 1.29
Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene. Biochem Biophys Res Commun (1984) 1.29
Actinomycin D: inhibition of phospholipid synthesis in chick embryo cells. Science (1968) 1.28
Interferon action on parental Semliki forest virus ribonucleic acid. J Virol (1967) 1.28
Antimitogenic effects of interferon and (2'-5')-oligoadenylate in synchronized 3T3 fibroblasts. FEBS Lett (1981) 1.26
The synthesis of N-acetylphenylalanyl-sRNA. Biochem Biophys Res Commun (1966) 1.23
Physical, morphological, and biochemical alterations in the membrane of AKR mouse cells after interferon treatment. Proc Natl Acad Sci U S A (1978) 1.23
Replication of Western equine encephalomyelitis virus. II. Cytoplasmic structure involved in the synthesis and development of the virions. J Virol (1968) 1.23
Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci U S A (1992) 1.22
Restriction of HIV replication in infected T cells and monocytes by interferon-alpha. AIDS Res Hum Retroviruses (1990) 1.21
Primary gene products of an arbovirus. Biochem Biophys Res Commun (1969) 1.20
Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene. Virology (2000) 1.19
Regulation of ppp(A2'p)nA-dependent RNase levels during interferon treatment and cell differentiation. Eur J Biochem (1985) 1.19
Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med (1983) 1.18
Analysis of the fusion of XC cells induced by homogenates of murine leukemia virus-infected cells and by purified murine leukemia virus. J Virol (1971) 1.17
Reconstitution of a deoxyribonuclease I-sensitive structure on active genes. Proc Natl Acad Sci U S A (1980) 1.16
Lateral crural strut graft: technique and clinical applications in rhinoplasty. Plast Reconstr Surg (1997) 1.16
A mouse cell line, which is unprotected by interferon against lytic virus infection, lacks ribonuclease F activity. Eur J Biochem (1981) 1.16
Inhibition by interferon of production of double-stranded Semliki forest virus ribonucleic acid. Nature (1965) 1.16
The effect of interferon on de novo infection of Moloney murine leukemia virus. Cell (1977) 1.16
Studies on polynucleotides. The linkage of deoxyribopolynucleotide templates to cellulose and its use in their replication. J Biol Chem (1974) 1.16
Translation of gag, pro, and pol gene products of human T-cell leukemia virus type 2. J Virol (1989) 1.15
Viral RNAs associated with ribosomes in Sindbis virus-infected HeLa cells. J Virol (1973) 1.15
Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity. Proc Natl Acad Sci U S A (1976) 1.14
Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures. J Virol (1991) 1.14
Inhibitory effects of lipophilic acids and related compounds on bacteria and mammalian cells. Antimicrob Agents Chemother (1975) 1.13
Inhibition of arbovirus protein synthesis by interferon. J Virol (1968) 1.12